Hosted on MSN11m
Morgan Stanley Upgrades Vir Biotechnology (VIR)Fintel reports that on January 9, 2025, Morgan Stanley upgraded their outlook for Vir Biotechnology (NasdaqGS:VIR) from Equal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback